This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stranden, A. M.
Right arrow Articles by Berger-Bachi, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stranden, A. M.
Right arrow Articles by Berger-Bachi, B.

 Previous Article  |  Next Article 

J. Bacteriol., Jan 1997, 9-16, Vol 179, No. 1
Copyright © 1997, American Society for Microbiology

Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus

AM Stranden, K Ehlert, H Labischinski and B Berger-Bachi
Institute of Medical Microbiology, University of Zurich, Switzerland.

The femAB operon is involved in the formation of the characteristic pentaglycine side chain of the staphylococcal peptidoglycan. Allele replacement of the femAB operon with the tetracycline resistance determinant tetK in a methicillin-resistant Staphylococcus aureus strain resulted in impaired growth, methicillin hypersusceptibility, and lysostaphin resistance. The usual pentaglycine cross-bridges were replaced by monoglycine bridges exclusively, and cross-linking of the peptidoglycan strands was drastically reduced. Complementation of the femAB null mutant by either femA or femAB resulted in the extension of the cross-bridges to a triglycine or a pentaglycine, respectively. This finding suggests that FemA is responsible for the formation of glycines 2 and 3, and FemB is responsible for formation of glycines 4 and 5, of the pentaglycine side chain of the peptidoglycan precursor. Moreover, it can be deduced that addition of the first glycine must occur by a femAB-independent mechanism.


This article has been cited by other articles:

  • Bernal, P., Zloh, M., Taylor, P. W. (2009). Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the {beta}-lactam resistance modifier (-)-epicatechin gallate. J Antimicrob Chemother 63: 1156-1162 [Abstract] [Full Text]  
  • RajBhandary, U. L., Soll, D. (2008). Aminoacyl-tRNAs, the bacterial cell envelope, and antibiotics. Proc. Natl. Acad. Sci. USA 105: 5285-5286 [Full Text]  
  • Julian, K., Kosowska-Shick, K., Whitener, C., Roos, M., Labischinski, H., Rubio, A., Parent, L., Ednie, L., Koeth, L., Bogdanovich, T., Appelbaum, P. C. (2007). Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis. Antimicrob. Agents Chemother. 51: 3445-3448 [Abstract] [Full Text]  
  • Stapleton, P. D., Shah, S., Ehlert, K., Hara, Y., Taylor, P. W. (2007). The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. Microbiology 153: 2093-2103 [Abstract] [Full Text]  
  • Oluola, O., Kong, L., Fein, M., Weisman, L. E. (2007). Lysostaphin in Treatment of Neonatal Staphylococcus aureus Infection. Antimicrob. Agents Chemother. 51: 2198-2200 [Abstract] [Full Text]  
  • Magnet, S., Arbeloa, A., Mainardi, J.-L., Hugonnet, J.-E., Fourgeaud, M., Dubost, L., Marie, A., Delfosse, V., Mayer, C., Rice, L. B., Arthur, M. (2007). Specificity of L,D-Transpeptidases from Gram-positive Bacteria Producing Different Peptidoglycan Chemotypes. J. Biol. Chem. 282: 13151-13159 [Abstract] [Full Text]  
  • Kusuma, C., Jadanova, A., Chanturiya, T., Kokai-Kun, J. F. (2007). Lysostaphin-Resistant Variants of Staphylococcus aureus Demonstrate Reduced Fitness In Vitro and In Vivo. Antimicrob. Agents Chemother. 51: 475-482 [Abstract] [Full Text]  
  • Fox, P. M., Lampen, R. J., Stumpf, K. S., Archer, G. L., Climo, M. W. (2006). Successful Therapy of Experimental Endocarditis Caused by Vancomycin-Resistant Staphylococcus aureus with a Combination of Vancomycin and {beta}-Lactam Antibiotics.. Antimicrob. Agents Chemother. 50: 2951-2956 [Abstract] [Full Text]  
  • Grundling, A., Missiakas, D. M., Schneewind, O. (2006). Staphylococcus aureus Mutants with Increased Lysostaphin Resistance.. J. Bacteriol. 188: 6286-6297 [Abstract] [Full Text]  
  • Bellais, S., Arthur, M., Dubost, L., Hugonnet, J.-E., Gutmann, L., van Heijenoort, J., Legrand, R., Brouard, J.-P., Rice, L., Mainardi, J.-L. (2006). Aslfm, the D-Aspartate Ligase Responsible for the Addition of D-Aspartic Acid onto the Peptidoglycan Precursor of Enterococcus faecium. J. Biol. Chem. 281: 11586-11594 [Abstract] [Full Text]  
  • Grundling, A., Schneewind, O. (2006). Cross-Linked Peptidoglycan Mediates Lysostaphin Binding to the Cell Wall Envelope of Staphylococcus aureus.. J. Bacteriol. 188: 2463-2472 [Abstract] [Full Text]  
  • Lu, J. Z., Fujiwara, T., Komatsuzawa, H., Sugai, M., Sakon, J. (2006). Cell Wall-targeting Domain of Glycylglycine Endopeptidase Distinguishes among Peptidoglycan Cross-bridges. J. Biol. Chem. 281: 549-558 [Abstract] [Full Text]  
  • Kusuma, C. M., Kokai-Kun, J. F. (2005). Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 49: 3256-3263 [Abstract] [Full Text]  
  • Maillard, A. P., Biarrotte-Sorin, S., Villet, R., Mesnage, S., Bouhss, A., Sougakoff, W., Mayer, C., Arthur, M. (2005). Structure-Based Site-Directed Mutagenesis of the UDP-MurNAc-Pentapeptide-Binding Cavity of the FemX Alanyl Transferase from Weissella viridescens. J. Bacteriol. 187: 3833-3838 [Abstract] [Full Text]  
  • Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Ehlert, K., Labischinski, H., Wilkinson, B. J. (2004). Cell Wall Composition and Decreased Autolytic Activity and Lysostaphin Susceptibility of Glycopeptide-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 48: 3749-3757 [Abstract] [Full Text]  
  • Arbeloa, A., Hugonnet, J.-E., Sentilhes, A.-C., Josseaume, N., Dubost, L., Monsempes, C., Blanot, D., Brouard, J.-P., Arthur, M. (2004). Synthesis of Mosaic Peptidoglycan Cross-bridges by Hybrid Peptidoglycan Assembly Pathways in Gram-positive Bacteria. J. Biol. Chem. 279: 41546-41556 [Abstract] [Full Text]  
  • Mongodin, E., Finan, J., Climo, M. W., Rosato, A., Gill, S., Archer, G. L. (2003). Microarray Transcription Analysis of Clinical Staphylococcus aureus Isolates Resistant to Vancomycin. J. Bacteriol. 185: 4638-4643 [Abstract] [Full Text]  
  • Kokai-Kun, J. F., Walsh, S. M., Chanturiya, T., Mond, J. J. (2003). Lysostaphin Cream Eradicates Staphylococcus aureus Nasal Colonization in a Cotton Rat Model. Antimicrob. Agents Chemother. 47: 1589-1597 [Abstract] [Full Text]  
  • Reipert, A., Ehlert, K., Kast, T., Bierbaum, G. (2003). Morphological and Genetic Differences in Two Isogenic Staphylococcus aureus Strains with Decreased Susceptibilities to Vancomycin. Antimicrob. Agents Chemother. 47: 568-576 [Abstract] [Full Text]  
  • Bouhss, A., Josseaume, N., Severin, A., Tabei, K., Hugonnet, J.-E., Shlaes, D., Mengin-Lecreulx, D., van Heijenoort, J., Arthur, M. (2002). Synthesis of the L-Alanyl-L-alanine Cross-bridge of Enterococcus faecalis Peptidoglycan. J. Biol. Chem. 277: 45935-45941 [Abstract] [Full Text]  
  • Reinscheid, D. J., Stosser, C., Ehlert, K., Jack, R. W., Moller, K., Eikmanns, B. J., Chhatwal, G. S. (2002). Influence of proteins Bsp and FemH on cell shape and peptidoglycan composition in group B streptococcus. Microbiology 148: 3245-3254 [Abstract] [Full Text]  
  • Kiri, N., Archer, G., Climo, M. W. (2002). Combinations of Lysostaphin with {beta}-Lactams Are Synergistic against Oxacillin-Resistant Staphylococcus epidermidis. Antimicrob. Agents Chemother. 46: 2017-2020 [Abstract] [Full Text]  
  • Komatsuzawa, H., Ohta, K., Yamada, S., Ehlert, K., Labischinski, H., Kajimura, J., Fujiwara, T., Sugai, M. (2002). Increased Glycan Chain Length Distribution and Decreased Susceptibility to Moenomycin in a Vancomycin-Resistant Staphylococcus aureus Mutant. Antimicrob. Agents Chemother. 46: 75-81 [Abstract] [Full Text]  
  • Boyle-Vavra, S., Carey, R. B., Daum, R. S. (2001). Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J Antimicrob Chemother 48: 617-625 [Abstract] [Full Text]  
  • Finan, J. E., Archer, G. L., Pucci, M. J., Climo, M. W. (2001). Role of Penicillin-Binding Protein 4 in Expression of Vancomycin Resistance among Clinical Isolates of Oxacillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45: 3070-3075 [Abstract] [Full Text]  
  • Beukes, M., Hastings, J. W. (2001). Self-Protection against Cell Wall Hydrolysis in Streptococcus milleri NMSCC 061 and Analysis of the Millericin B Operon. Appl. Environ. Microbiol. 67: 3888-3896 [Abstract] [Full Text]  
  • Bouhss, A., Josseaume, N., Allanic, D., Crouvoisier, M., Gutmann, L., Mainardi, J.-L., Mengin-Lecreulx, D., van Heijenoort, J., Arthur, M. (2001). Identification of the UDP-MurNAc-Pentapeptide:L-Alanine Ligase for Synthesis of Branched Peptidoglycan Precursors in Enterococcus faecalis. J. Bacteriol. 183: 5122-5127 [Abstract] [Full Text]  
  • Climo, M. W., Ehlert, K., Archer, G. L. (2001). Mechanism and Suppression of Lysostaphin Resistance in Oxacillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45: 1431-1437 [Abstract] [Full Text]  
  • Boyle-Vavra, S., Labischinski, H., Ebert, C. C., Ehlert, K., Daum, R. S. (2001). A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical Staphylococcus aureus Isolates. Antimicrob. Agents Chemother. 45: 280-287 [Abstract] [Full Text]  
  • Burnie, J. P., Matthews, R. C., Carter, T., Beaulieu, E., Donohoe, M., Chapman, C., Williamson, P., Hodgetts, S. J. (2000). Identification of an Immunodominant ABC Transporter in Methicillin-Resistant Staphylococcus aureus Infections. Infect. Immun. 68: 3200-3209 [Abstract] [Full Text]  
  • Ehlert, K., Tschierske, M., Mori, C., Schröder, W., Berger-Bächi, B. (2000). Site-Specific Serine Incorporation by Lif and Epr into Positions 3 and 5 of the Staphylococcal Peptidoglycan Interpeptide Bridge. J. Bacteriol. 182: 2635-2638 [Abstract] [Full Text]  
  • Komatsuzawa, H., Ohta, K., Sugai, M., Fujiwara, T., Glanzmann, P., Berger-Bachi, B., Suginaka, H. (2000). Tn551-mediated insertional inactivation of the fmtB gene encoding a cell wall-associated protein abolishes methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother 45: 421-431 [Abstract] [Full Text]  
  • Komatsuzawa, H., Ohta, K., Labischinski, H., Sugai, M., Suginaka, H. (1999). Characterization of fmtA, a Gene That Modulates the Expression of Methicillin Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 43: 2121-2125 [Abstract] [Full Text]  
  • Rohrer, S., Ehlert, K., Tschierske, M., Labischinski, H., Berger-Bachi, B. (1999). The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc. Natl. Acad. Sci. USA 96: 9351-9356 [Abstract] [Full Text]  
  • Navarre, W. W., Schneewind, O. (1999). Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope. Microbiol. Mol. Biol. Rev. 63: 174-229 [Abstract] [Full Text]  
  • Glanzmann, P., Gustafson, J., Komatsuzawa, H., Ohta, K., Berger-Bächi, B. (1999). glmM Operon and Methicillin-Resistant glmM Suppressor Mutants in Staphylococcus aureus. Antimicrob. Agents Chemother. 43: 240-245 [Abstract] [Full Text]  
  • Giesbrecht, P., Kersten, T., Maidhof, H., Wecke, J. (1998). Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin. Microbiol. Mol. Biol. Rev. 62: 1371-1414 [Abstract] [Full Text]  
  • Ton-That, H., Labischinski, H., Berger-Bachi, B., Schneewind, O. (1998). Anchor Structure of Staphylococcal Surface Proteins. III. ROLE OF THE FemA, FemB, AND FemX FACTORS IN ANCHORING SURFACE PROTEINS TO THE BACTERIAL CELL WALL. J. Biol. Chem. 273: 29143-29149 [Abstract] [Full Text]  
  • Ling, B., Berger-Bächi, B. (1998). Increased Overall Antibiotic Susceptibility in Staphylococcus aureus femAB Null Mutants. Antimicrob. Agents Chemother. 42: 936-938 [Abstract] [Full Text]  
  • Vaudaux, P. E., Monzillo, V., Francois, P., Lew, D. P., Foster, T. J., Berger-Bächi, B. (1998). Introduction of the mec Element (Methicillin Resistance) into Staphylococcus aureus Alters In Vitro Functional Activities of Fibrinogen and Fibronectin Adhesins. Antimicrob. Agents Chemother. 42: 564-570 [Abstract] [Full Text]  
  • Ichetovkin, I. E., Abramochkin, G., Shrader, T. E. (1997). Substrate Recognition by the Leucyl/Phenylalanyl-tRNA-protein Transferase. CONSERVATION WITHIN THE ENZYME FAMILY AND LOCALIZATION TO THE TRYPSIN-RESISTANT DOMAIN. J. Biol. Chem. 272: 33009-33014 [Abstract] [Full Text]  
  • Filipe, S. R., Pinho, M. G., Tomasz, A. (2000). Characterization of the murMN Operon Involved in the Synthesis of Branched Peptidoglycan Peptides in Streptococcus pneumoniae. J. Biol. Chem. 275: 27768-27774 [Abstract] [Full Text]  
  • Hegde, S. S., Shrader, T. E. (2001). FemABX Family Members Are Novel Nonribosomal Peptidyltransferases and Important Pathogen-specific Drug Targets. J. Biol. Chem. 276: 6998-7003 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»